Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer

Por García-Martínez, Elena, Gil, Ginés Luengo, Benito, Asunción Chaves, González-Billalabeitia, Enrique, Conesa, María Angeles Vicente, García, Teresa García, García-Garre, Elisa, Vicente, Vicente, de la Peña, Francisco Ayala
Publicado no Breast Cancer Res (2014)

Lrf suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion

Por Wang, Guocan, Lunardi, Andrea, Zhang, Jiangwen, Chen, Zhenbang, Ala, Ugo, Webster, Kaitlyn A., Tay, Yvonne, Gonzalez-Billalabeitia, Enrique, Egia, Ainara, Shaffer, David R., Carver, Brett, Liu, Xue-Song, Taulli, Riccardo, Kuo, Winston Patrick, Nardella, Caterina, Signoretti, Sabina, Cordon-Cardo, Carlos, Gerald, William L., Pandolfi, Pier Paolo
Publicado em 2013

Vulnerabilities of PTEN-p53-deficient prostate cancers to compound PARP/PI3K inhibition

Por González-Billalabeitia, Enrique, Seitzer, Nina, Song, Su Jung, Song, Min Sup, Patnaik, Akash, Liu, Xue-Song, Epping, Mirjam T., Papa, Antonella, Hobbs, Robin M., Chen, Ming, Lunardi, Andrea, Ng, Christopher, Webster, Kaitlyn A., Signoretti, Sabina, Loda, Massimo, Asara, John M., Nardella, Caterina, Clohessy, John G., Cantley, Lewis C., Pandolfi, Pier Paolo
Publicado em 2014